For many patients, the clinical benefits of GLP-1sparticularly sustained weight loss and metabolic improvementsare closely tied to continued use.[166] Once treatment is discontinued, individuals often experience weight regain and the return of obesity-related health conditions, underscoring the need to view obesity as a chronic condition that may require long-term treatment.[167] Adherence is also influenced by treatment tolerability.[168] While GLP-1s are generally well tolerated, side effects such as gastrointestinal symptoms and the inconvenience of regular self-injections may deter adherence for certain patients.[169] Recognizing the challenges associated with long-term adherence, pharmaceutical companies are innovating through the development of more-convenient delivery methods
Sip fluids regularly : Rather than drinking large volumes at once (which may worsen nausea), take small, frequent sips throughout the day
And the gap between "what the instructions say" and "what the syringe shows" feels dangerously wide
Six passed BPC-157, KPV, and TB-500 each by an 8-6 margin, MOTS-C by 7-5, Semax by 8-5, and Epitalon by 7-5
Your body is always communicating sometimes we just need the right framework to listen.